Yoder, Rachel
Kimler, Bruce F. http://orcid.org/0000-0001-7021-6964
Staley, Joshua M. http://orcid.org/0000-0001-9273-0286
Schwensen, Kelsey
Wang, Yen Y.
Finke, Karissa
O’Dea, Anne
Nye, Lauren
Elia, Manana
Crane, Gregory
McKittrick, Richard
Pluenneke, Robert
Madhusudhana, Sheshadri
Beck, Larry
Shrestha, Anuj
Corum, Larry
Marsico, Mark
Stecklein, Shane R. http://orcid.org/0000-0001-8322-5886
Godwin, Andrew K. http://orcid.org/0000-0002-3987-9580
Khan, Qamar J. http://orcid.org/0000-0002-6287-020X
Sharma, Priyanka http://orcid.org/0000-0001-8592-2239
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (Cancer Center Support Grant P30 CA168524, Cancer Center Support Grant P30 CA168524)
The University of Kansas Cancer Center; Merck & Co., Inc, Kenilworth, NJ, USA
Merck & Co., Inc, Kenilworth, NJ, USA
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 17 February 2022
Accepted: 10 June 2022
First Online: 11 July 2022
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: Mark Marsico reports salary, employment by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and ownership interest in Merck & Co., Inc., Kenilworth, NJ, USA; Priyanka Sharma reports consulting fees and contract research to the institution from Merck & Co., Kenilworth, NJ, USA Inc. All remaining authors report no potentially competing financial interests.